When combined withDFG-out Raf inhibitors, which block fatty acid desaturation by inducingproteasomal degradation of stearoyl-CoA desaturase (SCD1), LXRαactivation can trigger lipotoxicity-induced cancer cell death. The gene discussed is RAF1; the disease is cancer.